ArticleThe Journal of clinical investigation2023

Hemorrhage-activated NRF2 in tumor-associated macrophages drives cancer growth, invasion, and immunotherapy resistance.

Dominik J Schaer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.